publication venue for
- Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence. 37:100774-100774. 2023
- Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center. 36:100747-100747. 2023
- A single institution study evaluating outcomes of PD-L1 high KRAS-mutant advanced non-small cell lung cancer (NSCLC) patients treated with first line immune checkpoint inhibitors. 27:100330-100330. 2021
- Consolidative durvalumab outcomes in stage III non-small cell lung cancer in a multi-centre study. 29:100496-100496. 2021
- Salvage surgery for locally recurrent anal cancer after intensity modulated radiation therapy with concurrent chemotherapy. 26:100287-100287. 2021
- Applicability of the PACIFIC trial results in patients not eligible for the PACIFIC trial: Canadian rapid consensus statement and recommendations.. 25:100265-100265. 2020
- The impact of synchronous malignancies on survival in patients with early stage curable non-small-cell lung cancer. 25:100246-100246. 2020